Browsing Diğer Yayınlar Koleksiyonu by Department "İstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Tıbbi Farmakoloji Ana Bilim Dalı"
Now showing items 1-6 of 6
-
Analysis of pregnancy and lactation-related expressions in the summary of product characteristics and patient information leaflets of the drugs used for the treatment of nausea and vomiting
(Galenos Yayıncılık, 2021)Objective: Concerns and limited data on drug use in pregnancy and lactation raise the importance of relevant information in summary of product characteristics (SmPC) and patient information leaflets (PIL). This study aimed ... -
The effects of increased glucose level and glycolysis on SARS CoV-2 infection
(Bentham Science Publishers, 2022)COVID-19 has entered our lives as an infection with high mortality rates. Although the vaccination process has provided benefits, the death toll remains frightening worldwide. Therefore, drugs and combined therapies that ... -
Hedgehog signaling: Linking embryonic lung development and asthmatic airway remodeling
(MDPI, 2022)The development of the embryonic lung demands complex endodermal-mesodermal interactions, which are regulated by a variety of signaling proteins. Hedgehog (Hh) signaling is vital for lung development. It plays a key ... -
Kiralite kavramı ve ilaç güvenliliği ilişkisi: Geleneksel derleme
(Türkiye Klinikleri Yayınevi, 2022)Literatürde biyolojik sistemlerde yer alan objelerin ayna görüntüleriyle örtüşmeme durumları üzerinden ifade edilen kiralite, ilaçların vücutta ortaya çıkardığı etkiler bakımından önemli bir rol oynamaktadır. 1950’li ... -
Polycystic ovary syndrome: A disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies
(Frontiers Media SA, 2022)Polycystic ovary syndrome (PCOS) is a very common, complex, and heterogeneous endocrine disorder of women that involves a combination of environmental and genetic factors. PCOS affects women of growing age particularly at ... -
Protein and gene delivery systems for neurodegenerative disorders: Where do we stand today?
(MDPI, 2022)It has been estimated that every year, millions of people are affected by neurodegenerative disorders, which complicate their lives and their caregivers’ lives. To date, there has not been an approved pharmacological ...
